For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Nootropic & Cognitive · Comparison

Colostrinin vs Selank

A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

ColostrininSelank
CategoryNootropic & CognitiveNootropic & Cognitive
Also known asPRP (proline-rich polypeptide), ND, colostrum neuropeptide, CLN, ovine proline-rich polypeptideTP-7, Tuftsin analog
EvidenceResearch-stageResearch-stage
Dosing range100mcg–400mcg mcg, sublingual, on a 3 days on / 3 days off cycle250mcg–1000mcg mcg, 1–2x daily
AdministrationSublingual tablet/dropIntranasal (most common — direct CNS delivery), Subcutaneous injection
Key side effectsGenerally well-tolerated, Mild GI discomfort, Rare hypersensitivity (relevant for dairy protein sensitivity), Mild fatigue (initial days)Mild sedation at high doses, Nasal irritation (intranasal route), Generally very well-tolerated, No reported dependence or withdrawal
Cited sources2 references1 reference

Key differences

  • Administration: Colostrinin — Sublingual tablet/drop; Selank — Intranasal (most common — direct CNS delivery), Subcutaneous injection.
  • Frequency: Colostrinin is typically sublingual, on a 3 days on / 3 days off cycle; Selank is 1–2x daily.
  • Research depth: this profile cites 2 sources for Colostrinin vs 1 for Selank.

How each works

Colostrinin

Colostrinin modulates dendritic cell maturation and shifts cytokine balance toward anti-inflammatory patterns (reduced IL-6, TNF-α; increased IL-10). In neurological models, it reduces amyloid-β aggregation, decreases oxidative stress, and upregulates NGF while modulating the HPA axis stress response. A Polish double-blind trial showed statistically significant cognitive stabilization in mild-to-moderate AD patients over 15 weeks.

Selank

Selank modulates GABA-A receptors and influences BDNF expression, producing anxiolytic effects comparable to benzodiazepines without sedation or dependence. Russian clinical studies report improvements in generalized anxiety disorder, cognitive performance, and mood stability. It also appears to modulate T-helper cell ratios and interferon production.

Read the full Colostrinin profileRead the full Selank profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.